カテゴリー： QYResearch, 世界, 部品/材料

ニンテダニブエシル酸塩のグローバル市場2023年：純度98%、純度99%

◆英語タイトル：Global Nintedanib Esylate Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA1581）◆商品コード：QYR23MA1581
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：72
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のニンテダニブエシル酸塩市場について調査・分析し、世界のニンテダニブエシル酸塩市場概要、メーカー別競争状況、地域別生産量、地域別消費量、タイプ別セグメント分析（純度98%、純度99%）、用途別セグメント分析（医薬品中間体、有機中間体、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Zhejiang Zetian Fine Chemicals、Teva、Boehringer Ingelheim、Manus Aktteva Biopharma LLPなどが含まれています。世界のニンテダニブエシル酸塩市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間中の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争による影響は、ニンテダニブエシル酸塩市場規模を推定する際に考慮しました。

・ニンテダニブエシル酸塩市場の概要
- 製品の定義
- ニンテダニブエシル酸塩のタイプ別セグメント
- 世界のニンテダニブエシル酸塩市場成長率のタイプ別分析（純度98%、純度99%）
- ニンテダニブエシル酸塩の用途別セグメント
- 世界のニンテダニブエシル酸塩市場成長率の用途別分析（医薬品中間体、有機中間体、その他）
- 世界市場の成長展望
- 世界のニンテダニブエシル酸塩生産量の推定と予測（2018年-2029年）
- 世界のニンテダニブエシル酸塩生産能力の推定と予測（2018年-2029年）
- ニンテダニブエシル酸塩の平均価格の推定と予測（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ニンテダニブエシル酸塩市場の競争状況およびトレンド

・ニンテダニブエシル酸塩の地域別生産量
- ニンテダニブエシル酸塩生産量の地域別推計と予測（2018年-2029年）
- 地域別ニンテダニブエシル酸塩価格分析（2018年-2023年）
- 北米のニンテダニブエシル酸塩生産規模（2018年-2029年）
- ヨーロッパのニンテダニブエシル酸塩生産規模（2018年-2029年）
- 中国のニンテダニブエシル酸塩生産規模（2018年-2029年）
- 日本のニンテダニブエシル酸塩生産規模（2018年-2029年）
- 韓国のニンテダニブエシル酸塩生産規模（2018年-2029年）
- インドのニンテダニブエシル酸塩生産規模（2018年-2029年）

・ニンテダニブエシル酸塩の地域別消費量
- ニンテダニブエシル酸塩消費量の地域別推計と予測（2018年-2029年）
- 北米のニンテダニブエシル酸塩消費量（2018年-2029年）
- アメリカのニンテダニブエシル酸塩消費量（2018年-2029年）
- ヨーロッパのニンテダニブエシル酸塩消費量（2018年-2029年）
- アジア太平洋のニンテダニブエシル酸塩消費量（2018年-2029年）
- 中国のニンテダニブエシル酸塩消費量（2018年-2029年）
- 日本のニンテダニブエシル酸塩消費量（2018年-2029年）
- 韓国のニンテダニブエシル酸塩消費量（2018年-2029年）
- 東南アジアのニンテダニブエシル酸塩消費量（2018年-2029年）
- インドのニンテダニブエシル酸塩消費量（2018年-2029年）
- 中南米・中東・アフリカのニンテダニブエシル酸塩消費量（2018年-2029年）

・タイプ別セグメント：純度98%、純度99%
- 世界のニンテダニブエシル酸塩のタイプ別生産量（2018年-2023年）
- 世界のニンテダニブエシル酸塩のタイプ別生産量（2024年-2029年）
- 世界のニンテダニブエシル酸塩のタイプ別価格

・用途別セグメント：医薬品中間体、有機中間体、その他
- 世界のニンテダニブエシル酸塩の用途別生産量（2018年-2023年）
- 世界のニンテダニブエシル酸塩の用途別生産量（2024年-2029年）
- 世界のニンテダニブエシル酸塩の用途別価格

・主要企業のプロファイル：企業情報、製品ポートフォリオ、生産量、価格、動向
Zhejiang Zetian Fine Chemicals、Teva、Boehringer Ingelheim、Manus Aktteva Biopharma LLP

・産業チェーンと販売チャネルの分析
- ニンテダニブエシル酸塩産業チェーン分析
- ニンテダニブエシル酸塩の主要原材料
- ニンテダニブエシル酸塩の販売チャネル
- ニンテダニブエシル酸塩のディストリビューター
- ニンテダニブエシル酸塩の主要顧客

・ニンテダニブエシル酸塩市場ダイナミクス
- ニンテダニブエシル酸塩の業界動向
- ニンテダニブエシル酸塩市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

The global Nintedanib Esylate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Nintedanib Esylate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Nintedanib Esylate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Nintedanib Esylate include Zhejiang Zetian Fine Chemicals, Teva, Boehringer Ingelheim and Manus Aktteva Biopharma LLP, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nintedanib Esylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nintedanib Esylate.
The Nintedanib Esylate market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nintedanib Esylate market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nintedanib Esylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Zhejiang Zetian Fine Chemicals
Teva
Boehringer Ingelheim
Manus Aktteva Biopharma LLP
Segment by Type
98% Purity
99% Purity
Segment by Application
Pharmaceutical Intermediates
Organic Intermediate
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nintedanib Esylate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Nintedanib Esylate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Nintedanib Esylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Nintedanib Esylate Market Overview
1.1 Product Definition
1.2 Nintedanib Esylate Segment by Type
1.2.1 Global Nintedanib Esylate Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 98% Purity
1.2.3 99% Purity
1.3 Nintedanib Esylate Segment by Application
1.3.1 Global Nintedanib Esylate Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Pharmaceutical Intermediates
1.3.3 Organic Intermediate
1.3.4 Other
1.4 Global Market Growth Prospects
1.4.1 Global Nintedanib Esylate Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Nintedanib Esylate Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Nintedanib Esylate Production Estimates and Forecasts (2018-2029)
1.4.4 Global Nintedanib Esylate Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Nintedanib Esylate Production Market Share by Manufacturers (2018-2023)
2.2 Global Nintedanib Esylate Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Nintedanib Esylate, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Nintedanib Esylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Nintedanib Esylate Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Nintedanib Esylate, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Nintedanib Esylate, Product Offered and Application
2.8 Global Key Manufacturers of Nintedanib Esylate, Date of Enter into This Industry
2.9 Nintedanib Esylate Market Competitive Situation and Trends
2.9.1 Nintedanib Esylate Market Concentration Rate
2.9.2 Global 5 and 10 Largest Nintedanib Esylate Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Nintedanib Esylate Production by Region
3.1 Global Nintedanib Esylate Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Nintedanib Esylate Production Value by Region (2018-2029)
3.2.1 Global Nintedanib Esylate Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Nintedanib Esylate by Region (2024-2029)
3.3 Global Nintedanib Esylate Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Nintedanib Esylate Production by Region (2018-2029)
3.4.1 Global Nintedanib Esylate Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Nintedanib Esylate by Region (2024-2029)
3.5 Global Nintedanib Esylate Market Price Analysis by Region (2018-2023)
3.6 Global Nintedanib Esylate Production and Value, Year-over-Year Growth
3.6.1 North America Nintedanib Esylate Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Nintedanib Esylate Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Nintedanib Esylate Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Nintedanib Esylate Production Value Estimates and Forecasts (2018-2029)
4 Nintedanib Esylate Consumption by Region
4.1 Global Nintedanib Esylate Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Nintedanib Esylate Consumption by Region (2018-2029)
4.2.1 Global Nintedanib Esylate Consumption by Region (2018-2023)
4.2.2 Global Nintedanib Esylate Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Nintedanib Esylate Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Nintedanib Esylate Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Nintedanib Esylate Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Nintedanib Esylate Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Nintedanib Esylate Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Nintedanib Esylate Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Nintedanib Esylate Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Nintedanib Esylate Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Nintedanib Esylate Production by Type (2018-2029)
5.1.1 Global Nintedanib Esylate Production by Type (2018-2023)
5.1.2 Global Nintedanib Esylate Production by Type (2024-2029)
5.1.3 Global Nintedanib Esylate Production Market Share by Type (2018-2029)
5.2 Global Nintedanib Esylate Production Value by Type (2018-2029)
5.2.1 Global Nintedanib Esylate Production Value by Type (2018-2023)
5.2.2 Global Nintedanib Esylate Production Value by Type (2024-2029)
5.2.3 Global Nintedanib Esylate Production Value Market Share by Type (2018-2029)
5.3 Global Nintedanib Esylate Price by Type (2018-2029)
6 Segment by Application
6.1 Global Nintedanib Esylate Production by Application (2018-2029)
6.1.1 Global Nintedanib Esylate Production by Application (2018-2023)
6.1.2 Global Nintedanib Esylate Production by Application (2024-2029)
6.1.3 Global Nintedanib Esylate Production Market Share by Application (2018-2029)
6.2 Global Nintedanib Esylate Production Value by Application (2018-2029)
6.2.1 Global Nintedanib Esylate Production Value by Application (2018-2023)
6.2.2 Global Nintedanib Esylate Production Value by Application (2024-2029)
6.2.3 Global Nintedanib Esylate Production Value Market Share by Application (2018-2029)
6.3 Global Nintedanib Esylate Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Zhejiang Zetian Fine Chemicals
7.1.1 Zhejiang Zetian Fine Chemicals Nintedanib Esylate Corporation Information
7.1.2 Zhejiang Zetian Fine Chemicals Nintedanib Esylate Product Portfolio
7.1.3 Zhejiang Zetian Fine Chemicals Nintedanib Esylate Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Zhejiang Zetian Fine Chemicals Main Business and Markets Served
7.1.5 Zhejiang Zetian Fine Chemicals Recent Developments/Updates
7.2 Teva
7.2.1 Teva Nintedanib Esylate Corporation Information
7.2.2 Teva Nintedanib Esylate Product Portfolio
7.2.3 Teva Nintedanib Esylate Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Teva Main Business and Markets Served
7.2.5 Teva Recent Developments/Updates
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Nintedanib Esylate Corporation Information
7.3.2 Boehringer Ingelheim Nintedanib Esylate Product Portfolio
7.3.3 Boehringer Ingelheim Nintedanib Esylate Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Boehringer Ingelheim Main Business and Markets Served
7.3.5 Boehringer Ingelheim Recent Developments/Updates
7.4 Manus Aktteva Biopharma LLP
7.4.1 Manus Aktteva Biopharma LLP Nintedanib Esylate Corporation Information
7.4.2 Manus Aktteva Biopharma LLP Nintedanib Esylate Product Portfolio
7.4.3 Manus Aktteva Biopharma LLP Nintedanib Esylate Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Manus Aktteva Biopharma LLP Main Business and Markets Served
7.4.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Nintedanib Esylate Industry Chain Analysis
8.2 Nintedanib Esylate Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Nintedanib Esylate Production Mode & Process
8.4 Nintedanib Esylate Sales and Marketing
8.4.1 Nintedanib Esylate Sales Channels
8.4.2 Nintedanib Esylate Distributors
8.5 Nintedanib Esylate Customers
9 Nintedanib Esylate Market Dynamics
9.1 Nintedanib Esylate Industry Trends
9.2 Nintedanib Esylate Market Drivers
9.3 Nintedanib Esylate Market Challenges
9.4 Nintedanib Esylate Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ニンテダニブエシル酸塩のグローバル市場2023年：純度98%、純度99%(Global Nintedanib Esylate Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • L-イソプレゴールのグローバル市場2023年：純度98%、純度99%
  • 2-ペンタノンのグローバル市場2023年：純度98%、純度99%
  • クエン酸リチウムのグローバル市場2023年：純度98%、純度99%
  • 4-フェニル酪酸のグローバル市場2023年：純度98%、純度99%
  • ギ酸イソブチルのグローバル市場2023年：純度98%、純度99%

    • ◆H&Iグローバルリサーチのお客様（例）◆